CliffBio
small molecule

METHYLPHENIDATE HYDROCHLORIDE

METHYLPHENIDATE HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyTris. →See this company's full patent-cliff portfolio

Drug detail

Brand nameMETHYLPHENIDATE HYDROCHLORIDE
Active ingredientMETHYLPHENIDATE HYDROCHLORIDE
Strength5MG/5ML
Dosage formSOLUTION
RouteORAL
ModalitySmall molecule
FDA approvalJuly 2010
Marketing statusRX

More from Tris.

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

METHYLPHENIDATE HYDROCHLORIDE patent cliff — loss of exclusivity — | CliffBio